XML 81 R67.htm IDEA: XBRL DOCUMENT v3.25.0.1
Revenue Interest Purchase Agreement - Additional Information (Details) - Purchase Agreement - OrbiMed - USD ($)
12 Months Ended
Sep. 12, 2022
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Upfront payment received $ 125,000,000      
Potential revenue interest second payment to be received $ 75,000,000      
Purchase agreement, second payment date Sep. 12, 2025      
Potential revenue interest third payment to be received $ 50,000,000      
Purchase agreement, third payment date Sep. 12, 2025      
Revenue interest payment term 45 days      
Percentage of revenue interest payments 100.00%      
Percentage of cumulative purchaser payments 165.00%      
Cumulative purchaser payments repayment date Sep. 12, 2032      
Increase in return cap percentage of cumulative purchaser payments 175.00%      
Amortization of purchase agreement obligation   $ 0    
Effective interest rate   8.80%    
Debt issuance costs   $ 600,000    
Interest expense   11,580,000 $ 13,800,000 $ 4,200,000
Revenue interest payable   $ 2,372,000 $ 2,275,000  
Maximum        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Potential revenue interest payment to be received $ 125,000,000